Please login to the form below

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

NICE turns down Roche’s Tecentriq for triple-negative breast cancer

negative breast cancer (TNBC), an aggressive form of the disease with few treatment options. ... diagnosed with TNBC in England would be eligible for treatment with the regimen if an access deal can be agreed.

Latest news

NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig

did not specify how many previous treatment they had failed before taking the drug. ... Clearly this is not the result we’ve been working towards; with chronic migraine patients in England who could benefit from Aimovig being denied routine access to
Roche’s Hemlibra scores broader NHS funding

The market access agreement in England has been achieved once again via direct pricing and access negotiations with budget holder NHS England, with NICE not involved at all. ... This decision will mean that people will have the opportunity to have
NICE’s fast-track catapults Skyrizi into market

new psoriasis treatment gain market access in record time. ... Dr Alice Butler, UK medical director, AbbVie confirmed last month that Skyrizi’s NICE fast-track appraisal would make it the fastest ever market access approval for any psoriasis biologic
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

Somryst could facilitate patient access to CBTi treatment with appropriate clinical oversight and management from clinicians.”. ... to develop a similar CBT-based app for the treatment of major depressive disorder (MMD).
NICE backs CDF funding for Sanofi/Regeneron’s skin cancer drug Libtayo

The access agreement for Libtayo states that treatment can be continued until disease progression or for two years, whichever is sooner, as NICE thinks the data on the drug is “promising ... Around 560 people per year are eligible for treatment with

More from news
Approximately 1 fully matching, plus 207 partially matching documents found.

Latest Intelligence

Rare diseases: redefining medical communications

Low levels of clinical awareness and expertise, small patient populations, paucity of data, and access to treatment are all factors that drive the need for new approaches, compared with those used ... Access to treatment. The demonstration of value is
The Cystic Fibrosis Buyers’ Club

Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Diarmaid McDonald, lead organiser, Just Treatment. The
25 Women Leaders in UK Healthcare

with a rare condition for which there is no diagnosis, or no treatment, or where there is no access to new therapies on the NHS. ... greater access to diagnosis and treatment.
Gene therapy market access Q&A

Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... Getting this right is extremely important as a marketing authorisation is of little use to anyone if patients can’t access the treatment.
Bringing life to precision medicine

to identify which treatment will be most effective for the patient before treating that patient. ... The ability to perform such functionalised tests on hundreds of ‘patient avatars’ will give each patient access to the right treatment, the first time

More from intelligence
Approximately 1 fully matching, plus 43 partially matching documents found.

Latest appointments

UN names special envoy for HIV/ AIDS in Africa

Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
Basilea's Hans Christian Rohde takes up commercial role at uniQure

access to this crucial treatment to as many patients as possible.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Innovative pricing and contracting options

With rising treatment prices and healthcare spending, payer organisations are making efforts to contain costs. ... With rising treatment prices and healthcare spending, payer organisations are making efforts to contain costs, with the unintended
What is changing in mental health and dementia care?

dementia. Adult mental health. The Long-term Plan says thataccess to psychological therapies (IAPT) services will continue to expand so that 1.5m people will be able to access treatment each ... year by 2020/21, with an increasing focus on those with long
Battling breast cancer with precision medicine (Part 2)

I wanted her to access the best treatment possible. I also knew that carboplatin was especially effective when used with another chemotherapy called gemcitabine, as the two drugs are known to ... Then we hit another hurdle; there was no clinical trial
SWITCHED ONcology Patient Experience Focus Group Full Discussion

In the patient experience focus group, the discussion focused on the patient journey from pre-diagnosis right through to treatment and support. ... around treatment, access to information for both patients and hcps, patient support &wellbeing and the
18 SWITCHED ONcology: The Big Communication

Patients need high-quality information about IO, honest conversations about potential treatment response and access to experts who are familiar with this new treatment modality at every healthcare touchpoint. ... To make IO a successful treatment for